All Articles

A systematic review and network meta analysis of first-line immunotherapy for advanced urothelial carcinoma

Fenretinide in cancer therapy and chemoprevention: past, present and future

Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer

TRAP1 ablation improves mitochondrial cristae and oxidative phosphorylation in pancreatic cancer stem cells

Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy

Novel N-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance

Paired single cell analysis reveals chemotherapy resistance in osteosarcoma

Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications

Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance

Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies

Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance

Immunotherapy resistance and strategies in malignant pleural mesothelioma

Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption

From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

Evaluation of intracellular nucleotide pools in peripheral blood and bone marrow mononuclear cells and their association with frontline intensive chemotherapy response rates in AML patients

Extracellular vesicles shed by multidrug resistant cells contribute to the identification of SRC inhibitors as chemosensitizers in non-small cell lung cancer